Advertisement

Related Videos

R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, on Alternative Dispensing Strategies

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

Opening Session Panel Discussion

Daniel Goldstein, MD: Interventional Pharmacoeconomics - Why and How

Mark Sculpher, PhD: How Do We Assess the Value of Cancer Drug Optimization?

Advertisement

Advertisement




Mar
21
Today In Oncology
FDA Approves Chemoimmunotherapy Regimen for Hodgkin Lymphoma
Hypofractionated Locoregional RT in Early Breast Cancer
Melanoma-Specific Survival With Sentinel Lymph Node Biopsy
Breast Cancer Ultrasensitive ctDNA Assay Findings and Outcomes After Neoadjuvant Therapy
AMA Survey Finds Rapid Growth in Physician AI Adoption
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo